Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Governance Other
confidence 75%
filed 2026-07-16
Item 7.01
This disclosure is a company response to a Schedule 13D filing by activist investor Goldenwise Capital Group, which has demanded Board seats and challenged governance and strategy. The filing addresses Board composition, shareholder activism, and governance disputes—core governance matters. While the company disputes Goldenwise's claims and reaffirms confidence in its 2.0 Strategy, the substance is a governance dispute over Board control and leadership, not a specific governance event like an appointment, departure, or compensation arrangement. This is material because it discloses an active shareholder activism campaign that could affect Board composition and corporate control.
View raw filing on EDGAR →
6-K
Material Litigation
confidence 92%
filed 2026-07-16
EX-99.1
Brazil Potash discloses a procedural filing by the Brazilian Federal Public Defender's Office seeking to suspend provisional relief and overturn favorable court decisions regarding the Autazes Project. Although characterized as a procedural development within existing litigation rather than a new lawsuit, the filing directly threatens the Company's ability to continue installation activities on its flagship project and represents a material legal challenge that would affect a reasonable investor's assessment of project viability and timeline. The Company's detailed response and emphasis on its favorable judicial record underscore the materiality of this litigation development.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-07-16
Item 1.01
CrossAmerica Partners amended its Credit Agreement on July 15, 2026, extending the maturity date from March 31, 2028 to July 15, 2031, removing the SOFR credit spread adjustment, and amending financial covenants. While this is technically an amendment to an existing credit facility rather than a new issuance, it materially modifies the terms of a direct financial obligation and extends the debt maturity by three years, which is a significant capital structure event affecting the registrant's financial obligations. This falls under debt_issuance as the creation or material amendment of a direct financial obligation.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-16
Item 8.01
The filing discloses the consummation of a merger on July 14, 2026, whereby XOMA Royalty Holdings Corporation became the parent of XOMA Royalty Corporation following a holding company reorganization. The merger consideration consisted of $39.00 per share plus one CVR per share. This is a material change of control and completion of a merger transaction, which is the core M&A activity event type.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-16
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from BioAtla's Annual Meeting held July 16, 2026. The filing presents final voting tallies for three proposals: election of two Class III directors (Jay M. Short and Edward Williams), ratification of Ernst & Young LLP as independent auditor, and a non-binding advisory vote on named executive officer compensation. All three proposals passed with majority support, making this a routine but material governance disclosure that affects investor understanding of board composition and auditor appointment.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-16
Item 2.02
Alcoa Corporation issued a press release on July 16, 2026 announcing its second quarter 2026 financial results, including record quarterly revenue of $3.966 billion, net income of $407 million ($1.53 per share), and adjusted net income of $562 million ($2.12 per share). The disclosure is a standard quarterly earnings announcement filed under Item 2.02 with the press release attached as Exhibit 99.1, which is the typical format for earnings releases.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-07-16
Item 8.01
ASP Isotopes is retrospectively recasting prior-period financial information from its 2025 Form 10-K to present the construction services business (Skyline Builders) as discontinued operations following its March 29, 2026 deconsolidation. While the filing explicitly states this is "not an amendment to, or a restatement of, the 2025 Form 10-K," the retrospective recast of consolidated financial statements and MD&A to reclassify a material business segment from continuing to discontinued operations is a significant financial restatement in substance. This affects the comparability and interpretation of historical financial results and would materially affect a reasonable investor's assessment of the company's financial performance and composition.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-16
Item 5.02
The filing discloses the appointment of Jasper B. Sanfilippo, Jr. as Chief Executive Officer effective October 1, 2026, and Frank Pellegrino's appointment as President and Chief Financial Officer on the same date. While Jeffrey T. Sanfilippo's transition from CEO to Executive Chair is also mentioned, the principal disclosed actions are the two executive appointments to senior leadership roles, which would materially affect investor assessment of company leadership and governance.
View raw filing on EDGAR →
6-K
Periodic Quarterly
confidence 95%
filed 2026-07-16
The 6-K explicitly states in its Contents section that it contains "Exhibit 1: Second Quarter of 2026 Results." This is a periodic quarterly financial report for Q2 2026, not a discrete event or earnings press release. The filing is dated July 16, 2026, consistent with a second-quarter results disclosure. Although no exhibits were furnished in the body provided, the cover page clearly identifies the exhibit as quarterly results, which should be classified as a periodic quarterly report deferred for separate processing.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-16
Item 5.02
The filing discloses both a director departure (Minsok Pak's resignation on July 14, 2026) and a director appointment (Sudhanshu Priyadarshi's appointment on the same date to fill the vacancy). While both events occur, the substantive focus and disclosure detail center on the appointment of Priyadarshi, including his extensive background (CFO roles at Planet Fitness, KDP, Vista Outdoor; 14 years at PepsiCo), his committee assignments (Audit and Sustainability), and the Board's rationale for his selection. The appointment of a qualified director with significant finance and packaged-goods expertise is material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-07-16
Item 2.02
Simmons First National Corp disclosed Q2 2026 quarterly earnings results, reporting net income of $66.7 million and diluted EPS of $0.46, along with comprehensive financial metrics including net interest income, noninterest income/expense, loan portfolio performance, deposit trends, and asset quality measures. The earnings release and accompanying investor presentation were furnished as exhibits.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-16
Item 8.01
Michael Christenson was appointed as Chair of the Board on July 16, 2026, while continuing as CEO. Although Paul Zevnik's resignation as Board Chair is also disclosed, the principal action disclosed is Christenson's appointment to the Chair role, making this an executive appointment event. The consolidation of CEO and Chair roles in a single executive is material to governance structure and investor assessment.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-07-16
Item 1.01
Array Technologies entered into a definitive equity purchase agreement to acquire Affordable Wire Management, LLC for total consideration of approximately $203 million, consisting of a $153 million base purchase price plus deferred and performance-based earn-out payments payable in cash or common stock at ARRAY's election. The acquisition is expected to close in Q3 2026, expand ARRAY's balance-of-system portfolio, and be accretive to earnings.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-16
Item 8.01
FCPT completed the acquisition of 102 veterinary properties operated by Mission Pet Health for $268.0 million on July 16, 2026, generating $17.37 million in annual cash rent and contributing to record year-to-date acquisition volume of $364.3 million across 139 properties.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-16
Item 2.02
This is a standard earnings release disclosing DBV Technologies' financial results for the second quarter and half-year 2026, including operating income, R&D and SG&A expenses, net loss of $98.0 million for the six-month period, cash position of $174.9 million, and cash runway into Q3 2027. The press release is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures. The filing includes detailed financial statements and operational highlights relevant to investors assessing the company's financial condition and progress toward FDA approval of its VIASKIN® Peanut Patch.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 98%
filed 2026-07-16
EX-99.1
The exhibit is a press release announcing the declaration of quarterly dividends on Emera Inc.'s common shares and eight series of First Preferred Shares, with specific per-share amounts and payment dates. This is a routine but material dividend declaration that affects shareholders' returns and is disclosed as a discrete event announcement.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-07-16
Item 1.01
Distribution Solutions Group entered into a definitive Agreement and Plan of Merger on July 15, 2026, whereby LKCM Headwater Investments and affiliates will acquire all outstanding shares not already owned for $35.00 per share in cash (an 81% premium to pre-announcement closing price), resulting in the Company becoming a privately held subsidiary and ceasing to be publicly traded on Nasdaq upon completion. The transaction requires stockholder approval and HSR clearance.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-07-16
Item 2.03
Distribution Solutions Group amended its existing credit agreement with JPMorgan Chase Bank to introduce a 'certain funds' mechanism allowing revolving loans to fund the merger consideration, with a cap of $100 million in borrowings during the interim period.
View raw filing on EDGAR →
6-K
Earnings release
confidence 85%
filed 2026-07-16
EX-99.1
This is a press release dated July 16, 2026, providing an update on BW LPG's Product Services Q2 2026 segment performance, including gross trading results (USD -19 million), realised trading gains (USD 127 million), net results (USD -31 million), and Value-At-Risk metrics. While it is a segment-level update rather than full quarterly results, it discloses material financial performance metrics for a significant business division and explicitly states "The trading result will form part of the BW LPG Q2 2026 results, which will be released on 28 August 2026," confirming this is a component of the company's quarterly earnings disclosure.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 75%
filed 2026-07-16
EX-99.1
Blue Gold Ltd is soliciting shareholder votes on two material proposals at an Extraordinary General Meeting scheduled for July 24, 2026: (1) authorization for a reverse stock split at a ratio between 1:2 and 1:200 to address Nasdaq minimum bid price compliance, and (2) amendment and restatement of the Memorandum and Articles of Association to reflect the reverse split. The reverse stock split is material to investors as it directly addresses the company's trading price and listing status in response to delisting risk.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-16
Item 7.01
Forum Markets closed on the acquisition of a commercial aircraft engine for approximately $12 million in cash from Aero Engine Solutions, Inc., with an additional engine expected to close in the coming weeks. This represents a material acquisition of a real-world asset that expands the company's aviation portfolio and is expected to generate predictable cash flows. The Engine Sale and Purchase Agreement (Exhibit 10.1) and press release (Exhibit 99.1) document the completion of this transaction, which is a material acquisition event under Item 1.01 or 2.01 of Form 8-K.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-16
Item 2.02
New Horizon Aircraft Ltd. issued a press release on July 16, 2026 announcing its financial and operating results for the fiscal year ended May 31, 2026, with the press release furnished as Exhibit 99.1. The disclosure includes balance sheet strengthening to $78.3 million in cash, technical progress on the full-scale Cavorite X7 aircraft, and strategic partnerships—all material operational and financial updates that would affect a reasonable investor's assessment of the company's progress and financial position.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-07-16
Item 3.03
Purple Innovation implemented a 1-for-25 reverse stock split, approved by stockholders on July 2, 2026, and effective July 19, 2026. While the reverse split preserves percentage ownership and security holder rights, it is a material governance and capital structure event with significant market implications.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-07-16
The 6-K discloses the results of an Extraordinary General Meeting held on July 13, 2026, where shareholders voted on three proposals: (1) revision of terms for allotment of up to 5,000,000 Class B shares to Xingji Zhangpingting Limited with board-determined consideration; (2) approval of an offering of up to 10,000,000 Class A shares and filing of a Form F-1 registration statement with the SEC; and (3) authorization to adjourn the meeting if necessary. All three proposals passed with overwhelming majorities (99.99% for Proposals 1 and 2, 100% for Proposal 3). The approval of a material equity offering and share allotment makes this material to investors.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-07-16
Item 5.03
T3 Defense Inc. effected a 1-for-125 reverse stock split, approved by stockholders on June 24, 2026, and implemented via Certificate of Amendment filed with Delaware on July 15, 2026, effective July 20, 2026. The reverse split was undertaken to raise the per-share bid price above $1.00 and regain compliance with Nasdaq Listing Rule 5550(a)(2).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-16
Item 5.07 discloses the results of Versus Systems' annual shareholder meeting held July 16, 2026, with voting results for the election of four directors (Juan Carlos Barrera, David Catzel, Aric Spitulnik, and Luis Goldner) and a proposal to adjourn the meeting. All proposals were approved with clear majorities. This is a standard shareholder vote results disclosure required under Item 5.07 of Form 8-K.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-07-16
The filing discloses the appointment of George O'Leary as Interim Chief Financial Officer effective July 13, 2026, along with concurrent departures of the prior CFO (Jeremy Daniel) and COO (Duncan McGillivray). While the filing contains multiple executive transitions, the principal disclosed action centers on the appointment of O'Leary to the CFO role with specific compensation terms ($15,000/month, 35,000 stock options vesting upon Nasdaq listing). This is material as it affects the registrant's senior financial leadership and governance structure.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 85%
filed 2026-07-16
The 6-K discloses the appointment of Bo Lyu as an independent director and member of three board committees (audit, compensation, nominating and corporate governance) effective July 1, 2026. While the report also mentions the concurrent resignation of Jean Christophe Baron Von Pfetten, the principal disclosed action is the appointment of Mr. Lyu to fill the vacancy. The filing includes detailed biographical information and confirms his independence under Nasdaq and SEC rules, indicating material governance significance.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-16
Item 8.01
Quantum Cyber's subsidiary Quantum Drones Corporation closed the acquisition of a manufacturing facility in Bridgeport, Connecticut for $2.3 million on July 15, 2026, completing a material strategic acquisition announced via Letter of Intent on June 8, 2026 and formalized on June 29, 2026. This transaction marks the Company's transition from a technology licensing company to a vertically integrated autonomous defense manufacturer with domestic production capacity.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 85%
filed 2026-07-16
Item 1.01
VPR Brands disclosed settlement of a patent infringement litigation (R.J. Reynolds Vapor Company v. VPR Brands, LP, Case No. 1:26-cv-00459) involving a $14.9 million payment and grant of a perpetual, worldwide patent license. While the filing is technically under Item 1.01 (Material Definitive Agreement), the core event is resolution of material litigation through a settlement agreement, which is the salient disclosure for investor purposes.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-07-16
The 6-K discloses the results of an Extraordinary General Meeting held on July 10, 2026, where shareholders voted on seven proposals. The filing presents detailed vote tallies for each proposal, including the creation of Class A shares with 100 votes per share, a massive increase in authorized share capital (from 200 million to 100 trillion shares), and approval of amended memorandum and articles of association. These governance and capital structure changes are material to investors and directly correspond to Item 5.07 (shareholder vote results).
View raw filing on EDGAR →
6-K
Exec departure
confidence 75%
filed 2026-07-16
EX-99.1
Tamir Fayerman, a Board member and Audit Committee Chairman, resigned effective July 16, 2026 for personal reasons. While the press release also announces the appointment of Asaf Itzhaik as the new Audit Committee Chairman and Ohad Melnik-Marom as a new Board member, the principal disclosed action is Fayerman's departure from the Board and all committees. The loss of an Audit Committee Chairman is material to investors assessing governance and financial oversight.
View raw filing on EDGAR →
6-K
Legal Other
confidence 75%
filed 2026-07-16
EX-99.1
This exhibit is a formal response by Cementos Pacasmayo to an official letter (No. 3113-2026-SMV/11.1) from Peru's Superintendency of the Securities Market (SMV) regarding disclosure obligations related to Holcim's acquisition of controlling interest and the mandatory tender offer. The company's response addresses regulatory compliance questions about what material events were required to be disclosed under Peruvian securities law, including arguments about the scope of disclosure obligations for share purchase agreements, due diligence reports, and valuation documents. This is a regulatory/legal matter involving securities law compliance and disclosure obligations, not a discrete operational or financial event, making it a legal_other classification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-16
Item 5.07
This Item 5.07 disclosure reports the final results of Treasure Global Inc's 2026 Annual Stockholders Meeting held on July 14, 2026, including the election of seven directors and ratification of WWC, P.C. as the independent auditor. The detailed vote tallies for each director nominee and the auditor ratification proposal are the core content, making this a textbook shareholder vote results disclosure.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-07-16
EX-99.1
The Company received a written notification from Nasdaq on July 14, 2026, stating non-compliance with Nasdaq Listing Rule 5250(c)(2) due to failure to file a Form 6-K containing interim financial statements for the six-month period ended December 31, 2025. The Company has 60 calendar days to submit a compliance plan, with potential extension to 180 days. The notice explicitly states "There can be no assurance that the Company's plan will be accepted or the Company will be able to regain compliance," and the Company will be listed as a non-compliant issuer. This is a clear delisting-risk disclosure under Item 3.01 equivalent.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-16
Item 5.07
Plum IV shareholders voted on July 10, 2026 to approve an Extension Amendment extending the business combination deadline from July 16, 2026 to January 16, 2027, with optional monthly extensions up to July 16, 2027. The proposal passed with 17,581,000 votes in favor, 2,132,072 against, and 52 abstentions, representing 81.32% of voting power.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-07-16
Item 8.01
In connection with the Extension Amendment vote, shareholders redeemed 145 million dollars of trust account funds and the Sponsor and directors converted Class B shares to Class A shares, materially restructuring the company's capital structure and reducing available trust account funds to $39.7 million.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-07-16
The 6-K discloses that the SEC suspended trading in the Company's securities from June 12–26, 2026, and that Nasdaq subsequently halted trading in the Company's Class A ordinary shares pending satisfaction of an information request. The Company submitted its response on July 10, 2026, but trading remains halted with "no assurance as to when, or whether, trading in the Company's Class A ordinary shares will resume." This is a material delisting risk — the registrant faces a continued listing threat and loss of trading access, which directly threatens investor liquidity and the registrant's capital-raising ability.
View raw filing on EDGAR →
6-K
Periodic Interim
confidence 95%
filed 2026-07-16
This 6-K furnishes unaudited condensed consolidated financial statements for the six months ended March 31, 2026, including balance sheets, statements of operations and comprehensive loss, statements of changes in shareholders' deficit, and statements of cash flows, along with MD&A. This is a periodic interim financial report (the foreign-issuer equivalent of a 10-Q), not a discrete event or earnings press release. The report shows significant operational and financial challenges (net loss of RMB 17.9 million, shareholders' deficit of RMB 871.4 million), making it material to investors' assessment of the registrant's financial condition.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-07-16
EX-99.1
The press release discloses that Cellyan received a Nasdaq notification letter on July 14, 2026 granting an additional 180-day compliance grace period (until January 11, 2027) to regain compliance with the Nasdaq minimum $1.00 closing bid price requirement. The Company must maintain a closing bid price of at least $1.00 per share for ten consecutive business days to avoid delisting. This is a material disclosure of delisting risk under Item 3.01 equivalent, as it directly threatens the Company's continued listing on Nasdaq and would materially affect a reasonable investor's assessment of the registrant's status.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 98%
filed 2026-07-16
EX-99.1
The press release discloses a Nasdaq notification that Ohmyhome has failed to maintain the minimum bid price of $1.00 per share required under Nasdaq Listing Rule 5550(a)(2). The Company has been granted a 180-day compliance period (until January 11, 2027) to regain compliance, with potential for an additional 180-day extension if certain conditions are met. This is a classic delisting-risk disclosure under Item 3.01 — the Company faces potential delisting if it cannot restore its share price above $1.00 within the cure period.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-07-16
Item 2.01
SpringBig Holdings completed a reorganization whereby secured lenders transferred all equity interests in the operating subsidiary (SpringBig, Inc.) to Lightbank II, L.P. and LS Round II, LLC, resulting in the Company being released from approximately $12.5 million in debt obligations but losing control of substantially all its assets and undergoing a material change of control.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-16
Item 5.02
Andrew Jay Glashow was appointed as a Class I director and Chief Executive Officer of SpringBig Holdings, effective July 10, 2026, representing a material change in the Company's leadership.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-16
Item 7.01
The disclosure announces the launch of "FLASHSM," a direct-to-consumer mobile application for cricket streaming and fan engagement, representing a significant strategic expansion into direct-to-consumer distribution. This is a material operational and strategic business event—the company is executing a core element of its stated strategy to "build a leading, cricket-focused sports and media platform" and establish direct relationships with fans. While the event is clearly operational in nature, it does not fit neatly into a specific named category (e.g., it is not a workforce reduction, material contract, or regulatory milestone in the traditional sense), making `operational_other` the most appropriate classification.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-16
Item 1.01
USA Rare Earth entered into Amendment No. 1 to its Merger Agreement with SVRE Holdings Ltd. on July 16, 2026, which modifies closing conditions by making an offtake agreement with a U.S. government-backed special purpose vehicle a condition precedent to completion. The underlying merger, originally dated April 19, 2026, involves USAR issuing 126.8 million shares and paying $300 million in cash consideration.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 98%
filed 2026-07-16
HEICO executed an Underwriting Agreement on July 13, 2026, and completed a public offering on July 16, 2026, of $550 million in 4.950% Senior Notes due 2031 and $650 million in 5.400% Senior Notes due 2036, totaling $1.2 billion in principal amount. The filing discloses the creation of direct financial obligations under Item 1.01 (Entry into Material Definitive Agreement) and Item 2.03 (Creation of Direct Financial Obligation), with the company intending to use net proceeds to pay down existing credit facility borrowings. This is a material debt issuance event.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-16
Item 7.01
The filing discloses completion of a material acquisition of Kira Pharmaceuticals by Jasper Therapeutics in an all-stock transaction, combined with a concurrent $132 million private placement financing. The press release explicitly states "Jasper has completed the acquisition of Kira Pharmaceuticals" and describes a consolidated pipeline, management structure, and significant ownership dilution (Jasper pre-acquisition shareholders will own ~6.68% post-transaction). This is a transformative M&A event material to investors.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-07-16
Item 1.01
Mercator Acquisition Corp. consummated its IPO on July 10, 2026, raising $172.5 million in gross proceeds through issuance of 17.25 million units and entering into multiple material definitive agreements (underwriting, warrant, trust, registration rights, and warrant purchase agreements) that constitute the IPO structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-16
Item 3.02
Mercator Acquisition Corp. completed a private placement of 4,500,000 warrants to the Sponsor and Underwriter at $1.00 per warrant, generating $4.5 million in gross proceeds pursuant to Section 4(a)(2) exemption from registration.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-16
EX-99.1
This press release announces a clinical development milestone: the first patient dosed in the intermittent weekly dosing arm of a Phase 1 trial for AN9025, a pan-RAS(ON) inhibitor. While the company is clinical-stage and this represents progress in its lead therapeutic candidate, the disclosure is a clinical milestone rather than a discrete material event (M&A, restatement, executive change, etc.). The announcement is material to investors assessing the company's pipeline advancement and clinical strategy, but does not fit the specific event-type taxonomy; it is an operational/strategic milestone in drug development.
View raw filing on EDGAR →